OXULAR LIMITED

🇬🇧Reino Unido•Private Limited Company (Ltd.)•Activa

Resumen

PaísReino Unido

EstadoActiva

Número de registro09331313

Fundada27/11/2014

Objeto socialResearch and experimental development on biotechnology

DirecciónThe Charter Building, Vine Street, Uxbridge, Middlesex, UB8 1JG

Declaración de confirmaciónPróximo vencimiento: —; Última elaboración: —

Legal y estado

Forma legalPrivate Limited Company (Ltd.)

EstadoActiva

Fecha de registro27/11/2014

Autoridad registralCompanies House

Capital registrado—

Fuente: UK Companies House · Última actualización: 3/12/2025

Línea temporal (8 eventos)

1/2/2025

Dirección actualizada

The Charter Building, Vine Street, Uxbridge, Middlesex, Ub8 1JG

20/12/2024

Nombramiento Mark Volpe (persona)

Nombrado como Director

27/11/2014

Empresa constituida

Fecha de constitución: 2014-11-27

Métrica	2020	2021	2023
Beneficio / (pérdida)	£-3.170.415	£-5.307.484	£-13.724.773
Activo total	£3.400.135	£2.677.145	£44.820
Net Assets Liabilities	£3.855.536	£1.225.197	£3.016.053
Equity	£3.625.816	£3.855.536	£16.696.006
Current Assets	£4.446.466	£5.217.845	£14.622.305
Issue Equity Instruments	£3.400.135	£2.677.145	£860
Number Shares Issued Fully Paid	57.249	55.631	400
Par Value Share	£1	£1	£0
Applicable Tax Rate	£0	£0	£0
Cancellation Subscribed Capital Decrease In Equity	—	—	£-7503
Cash Cash Equivalents	£3.125.278	£3.374.813	£9.799.580
Comprehensive Income Expense	£-3.170.415	£-5.307.484	£-13.724.773
Current Liabilities	£607.144	£523.896	£12.137.038
Further Item Increase Decrease In Equity Component Total Income Expense Recognised Directly In Equity	—	—	£36.457
Income Expense Recognised Directly In Equity	£3.400.135	£2.677.145	£44.820
Nominal Value Shares Issued In Period	£340	£0	£0
Non-current Liabilities	£0	£3.473.775	£0
Number Shares Authorised	57.249	55.631	400
Number Shares Issued But Not Fully Paid	—	—	860
Number Shares Issued In Period- Gross	340	0	0
Number Shares Redeemed In Period	0	—	-7503
Property Plant Equipment Including Right-of-use Assets	£16.214	£5023	£530.786
Total Borrowings	£0	£3.473.775	—
Trade Other Payables	£607.144	£523.896	£12.137.038
Trade Other Receivables	£1.321.188	£1.843.032	£4.822.725

Métrica

2020

2021

2023

Beneficio / (pérdida)

£-3.170.415

£-5.307.484

£-13.724.773

Activo total

£3.400.135

£2.677.145

£44.820

Net Assets Liabilities

£3.855.536

£1.225.197

£3.016.053

Equity

£3.625.816

£3.855.536

£16.696.006

Current Assets

£4.446.466

£5.217.845

£14.622.305

Issue Equity Instruments

£3.400.135

£2.677.145

£860

Number Shares Issued Fully Paid

57.249

55.631

400

Par Value Share

£1

£0

Applicable Tax Rate

£0

Cancellation Subscribed Capital Decrease In Equity

—

£-7503

Cash Cash Equivalents

£3.125.278

£3.374.813

£9.799.580

Comprehensive Income Expense

£-3.170.415

£-5.307.484

£-13.724.773

Current Liabilities

£607.144

£523.896

£12.137.038

Further Item Increase Decrease In Equity Component Total Income Expense Recognised Directly In Equity

—

£36.457

Income Expense Recognised Directly In Equity

£3.400.135

£2.677.145

£44.820

Nominal Value Shares Issued In Period

£340

£0

Non-current Liabilities

£0

£3.473.775

£0

Number Shares Authorised

57.249

55.631

400

Number Shares Issued But Not Fully Paid

—

860

Number Shares Issued In Period- Gross

340

Number Shares Redeemed In Period

—

-7503

Property Plant Equipment Including Right-of-use Assets

£16.214

£5023

£530.786

Total Borrowings

£0

£3.473.775

—

Trade Other Payables

£607.144

£523.896

£12.137.038

Trade Other Receivables

£1.321.188

£1.843.032

£4.822.725

Nombre	Participación	Voto	Desde

Nombre	Participación	País	Desde

OXULAR LIMITED

Resumen

Legal y estado

Línea temporal (8 eventos)

Dirección actualizada

Nombramiento Mark Volpe (persona)

Empresa constituida

Red

Propiedad y gestión

Persons with significant control

Officers & directors

Línea temporal de propiedad (1 cambios)

Nombramiento Unknown Owner (empresa)

Accionistas

Beneficiario final

Geografía

Finanzas

Cifras clave

Documentos

Informe de la empresa OXULAR LIMITED

Annual Accounts

Annual Accounts

Companexia Document AI

Annual Accounts

Explorar más empresas y personas

Salud financiera

Crecimiento

Eficiencia y rentabilidad

Capital circulante y liquidez

Estructura de capital